Acuson will introduce a relatively inexpensive ultrasound scannersans color-flow Doppler at the American Institute of Ultrasoundin Medicine meeting in Atlanta this week. The move does not signalAcuson's intention to become a mid- and low-tier ultrasound
Acuson will introduce a relatively inexpensive ultrasound scannersans color-flow Doppler at the American Institute of Ultrasoundin Medicine meeting in Atlanta this week. The move does not signalAcuson's intention to become a mid- and low-tier ultrasound manufacturer,however, according to Clay Larsen, radiology marketing manager.
"We see an increasing need for high-performance, black-and-white-onlysystems in the marketplace. We have heard this from our customersand are filling a market need that is out there," he toldSCAN. "If this expands our opportunities into other markets--sayperinatology or obstetrics--that is an upside opportunity. Certainly,this is not a mid-range, office-type system."
The 128 XP3 will sell in the range of $90,000 to $120,000,compared to the XP10, which hovers around $200,000. Acuson maintainedwhen the XP system was released in July that it is more configurablethan the vendor's previous platform. System configurability allowsfor the introduction of a variety of scanner mainframes basedon the same basic 128-channel platform, he said.
"It (the XP) has increased our ability to react wherewe see demands in the marketplace--and not only upward,"Larsen said. "It is still a premium-performance system, butit is for people who want high performance but can't justify theextra cost for color and other options."
The XP3 does not include vector-array technology that was introducedwith the XP10. It does have sector scanning, however, he said.
The primary use of the XP3 is expected to be as a second systemfor radiology departments in need of extra capacity.
"Instead of buying a different system than the one theirsonographers are familiar with, many Acuson customers would appreciatehaving the Acuson performance (in a lower cost second scanner).They can also share transducers between systems," Larsensaid.
It is also likely that obstetricians, urologists and otherprivate-practice physicians may seize the opportunity to buy ahospital-grade ultrasound system for less money. Many privateoffices, pressed by competition for referrals, would like to owna higher performance scanner but can't justify an $80,000 pricedifferential, he said.
"The desire for hospital-grade equipment has always beenthere, but now it is going to be somewhat more within the reachof private offices," Larsen said.
Expanding into mid-tier scanners might help Acuson competeagainst competitors such as Toshiba, particularly in internationalmarkets. The high-end ultrasound leader wants to keep its qualityreputation, however.
"There is still tremendous growth opportunity in the hospital-grade,premium-performance line of equipment, both in the U.S. and internationally,"Larsen said.
Improving Adherence to Best Practices for Incidental Abdominal Aortic Aneurysms on CT and MRI
November 5th 2024In recent interviews, Eric Rohren, M.D., and Krishna Nallamshetty, M.D., discuss the potential of abdominal aortic aneurysms (AAAs) to progress into life-threatening consequences and an emerging AI-powered tool that may bolster adherence to best practice recommendations in radiology reporting of incidental AAA findings on CT and MRI.
Can MRI-Based AI Enhance Pre-Op Prediction of Tumor Deposits in Patients with Rectal Cancer?
October 31st 2024For patients with rectal cancer, an emerging nomogram that combines deep learning and clinical factors had greater than 16 percent and 23 percent increases in accuracy and specificity, respectively, for pre-op prediction of tumor deposits in comparison to clinical factors alone.
Artifact Reduction Drives Technology Advances with Updated Version of Echelon Synergy MRI System
October 30th 2024Emerging technologies included with the 10th version of the 1.5T MRI platform include Synergy DLR Clear and Synergy Vision that are geared toward mitigating common challenges with artifacts.
AI Segmentation, Intraprostatic Tumor Volume and Metastases: What a New mpMRI Study Reveals
October 29th 2024For patients who received radiotherapy for localized prostate cancer, total intraprostatic tumor volume derived from AI segmentation had a 10 percent higher AUC for predicting seven-year metastases in comparison to a risk model from the National Comprehensive Cancer Network (NCCN).